Estrogen and Heart Health: What We Believe Now

Media Formats

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details

Presenters

Overview
After the initial findings from the Women’s Health Initiative were published, hormone replacement therapy in menopause stopped practically overnight. But the first analysis may not be the last word. Our guest today is Dr. Richard Karas, Professor of Medicine at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard. We are discussing the effects of hormone replacement therapy in menopause on the risk of cardiovascular disease.

Recommended

Details

Presenters

Overview
After the initial findings from the Women’s Health Initiative were published, hormone replacement therapy in menopause stopped practically overnight. But the first analysis may not be the last word. Our guest today is Dr. Richard Karas, Professor of Medicine at the Tufts University School of Medicine in Boston. He has several titles including: Co-Director, Molecular Cardiology Research Center, Director, Preventive Cardiology and Director, Women’s Heart Center at the New England Medical Center. He received his MD from Tufts and his Ph.D in Physiology from Harvard. We are discussing the effects of hormone replacement therapy in menopause on the risk of cardiovascular disease.